Actual Medicinal Product (AMP) Zaponex 25mg tablets (Leyden Delta B.V.)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Light sensitive medicine. Store in light resistant container. Moisture sensitive medicine. Store in an airtight container. Mixed results from stability studies (Studies show chemical stability in airtight containers up to 6 weeks but may discolour and crumble)
- Provenance
-
This recommendation is based on the products Denzapine 25mg tablets (Britannia Pharmaceuticals Ltd) and Clozapine 25mg tablets (Viatris).
- Generic
- Clozapine
- Formulation
- Clozapine 25mg tablets
-
Clozapine
-
Clozapine 25mg tablets
-
Zaponex 25mg tablets (Leyden Delta B.V.)
-
-